Biosolution Co., Ltd.: Clinical Trials

2 unknown. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Unknown 2

Follow Biosolution Co., Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Phase 3 Clinical Trial of CartiLife® in Korea Autologous Chondrocyte Implantation (CartiLife®), Microfracture Surgery - Articular Cartilage Defect, Articular Cartilage Degeneration	Phase 3	Unknown	Biosolution Co., Ltd.	104	2020-03-19	2022-05-17
Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood Autologous cultured keratinocyte cell - Burn Wound	Phase 3	Unknown	Biosolution Co., Ltd.	19	2007-11-01	2009-09-17

Conditions studied

Burns (1)

Countries

South Korea (2)

Top investigators

Chong Bum Chang, MD (1)  ·  Dong Hwi Kim, MD (1)  ·  Hyuk-Soo Han, MD (1)  ·  Jae Doo Yoo, MD (1)  ·  Ji Hoon Bae, MD (1)  ·  Jong Geun Seon, MD (1)  ·  Joon Ho Wang, MD (1)  ·  Jungsun Lee, Ph.D (1)  ·  Kyoung Ho Yoon, MD (1)  ·  Min Jung, MD (1)  ·  Sang Hak Lee, MD (1)  ·  Sang Won Moon, MD (1)  ·  Seok Jung Kim, MD (1)  ·  Seung Joon Rhee, MD (1)  ·  Sung-Hwan Kim, MD (1)